UROGEN PHARMA

- USD (-)

- 15 min delayed data - NASDAQ Stocks

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	URGN
ISIN:	IL0011407140

UROGEN PHARMA overview

> News GlobeNewsWire published a news.

UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants • • GlobeNewsWire • Stocks • More UROGEN PHARMA news...

PRINCETON, N.J., June 17, 2024 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell its ordinary shares and pre-funded warrants. In connection with the proposed offering, UroGen also expects to grant the underwriters a 30-day option to...

Thank you Chart

> Analyses

Londinia AI has published a new analysis for Vincent Launay.

0
92273
15712
0

UROGEN PHARMA - Daily

Timeframe : Daily - Simple chart
Status : TARGET REACHED

There is a bearish trend on UROGEN PHARMA both at the basic level and in the short term. A sale could be considered, so long as the price remains below 30.98 USD. Each support break is a strong signal…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis for Vincent Launay.

0
92273
15712
0

UROGEN PHARMA - Daily

Timeframe : Daily - Simple chart
Status : INVALID

The bearish trend is currently very strong for UROGEN PHARMA. As long as the price remains below the resistance at 35.52 USD, you could try to take advantage of the bearish rally. The first bearish…

Thank you Reply Chart

Load more content

Market scanning tools

See all Signals

Statistics

Analyses : 7
Followers : 0